Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches. | Cancers (Basel) | 2023 | 38001644 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics. | Biology (Basel) | 2023 | 37997979 | PubTator, text mining | PubMed |
| Quantification of ligand and mutation-induced bias in EGFR phosphorylation in direct response to ligand binding. | Nat Commun | 2023 | 37989743 | PubTator, text mining | PubMed |
| Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations. | Nat Commun | 2023 | 37978175 | PubTator, text mining | PubMed |
| Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis. | Int J Mol Sci | 2023 | 37958993 | PubTator, text mining | PubMed |
| The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. | Int J Mol Sci | 2023 | 37958796 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. | Cancers (Basel) | 2023 | 37958352 | PubTator, text mining | PubMed |
| Anaplastic lymphoma kinase inhibitors-a review of anticancer properties, clinical efficacy, and resistance mechanisms. | Front Pharmacol | 2023 | 37954850 | PubTator, text mining | PubMed |
| SMG: self-supervised masked graph learning for cancer gene identification. | Brief Bioinform | 2023 | 37950905 | PubTator, text mining | PubMed |
| The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer. | Sci Rep | 2023 | 37945594 | PubTator, text mining | PubMed |
| Diverse activity of miR-150 in Tumor development: shedding light on the potential mechanisms. | Cancer Cell Int | 2023 | 37924077 | PubTator, text mining | PubMed |
| Prognostic significance of molecular subgroups in survival outcome for children with medulloblastoma in Malaysia. | Front Oncol | 2023 | 37920166 | PubTator, text mining | PubMed |
| Association of XIST/miRNA155/Gab2/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory mediators. | Sci Rep | 2023 | 37914735 | PubTator, text mining | PubMed |
| Erratum: Growth Factor Receptor Bound Protein 2-Associated Binder 2, a Scaffolding Adaptor Protein, Negatively Regulates Host Immunity against Tuberculosis. | Am J Respir Cell Mol Biol | 2023 | 37909697 | PubTator, text mining | PubMed |
| Navigating the ERK1/2 MAPK Cascade. | Biomolecules | 2023 | 37892237 | PubTator, text mining | PubMed |
| Clinical advances in immunotherapy for immune-mediated glomerular diseases. | Clin Exp Med | 2023 | 37889398 | PubTator, text mining | PubMed |
| The ErbB Signaling Network and Its Potential Role in Endometrial Cancer. | Epigenomes | 2023 | 37873809 | PubTator, text mining | PubMed |
| Effect of Harvey Rat Sarcoma Virus Mutation in Oral Squamous Cell Carcinoma and Its Influence on Different Populations: A Systematic Review. | Cureus | 2023 | 37868370 | PubTator, text mining | PubMed |
| A PINK1 input threshold arises from positive feedback in the PINK1/Parkin mitophagy decision circuit. | Cell Rep | 2023 | 37851575 | PubTator, text mining | PubMed |
| MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target. | Cancers (Basel) | 2023 | 37835473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=6